entertainment -WSS

entertainment

author：knowledge 2025-08-12 09:10:16 - browse：45

Monica Bertagnolli -- Health Policy coverage from STAT — Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) Jeff Chiu/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica Bertagnolli, President Biden’s nominee to run the National Institutes of Health, he said Friday.

Sanders, whose health committee oversees the confirmation of the NIH nominee, had refused to hold a hearing on Bertagnolli until the Biden administration promised more drug pricing reform.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care.

Please enter a valid email address. Privacy Policy

HHS announced Friday a deal with Regeneron on the development of the Covid-19 monoclonal antibody. That deal seems to have satisfied Sanders’ demands, though Sanders said the administration must add reasonable pricing provisions to all drugs developed with the help of government funding.

“I welcome the Biden Administration’s announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries,” Sanders said in a release.

Sen. Elizabeth Warren (D-Mass.) also had withheld support for Bertagnolli’s nomination until Bertagnolli agreed to Warren’s ethics demands. Bertagnolli agreed to not join the pharmaceutical industry or accept payment from the drug industry, until at least four years after leaving her government position.

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： A clever new way to fix Medicaid and graduate medical education

WSS

Novo acquires Inversago for up to $1 billion

White House calls on federal agencies to crack down on AI abuses

HPV cancer vaccine study demonstrates efficacy

Medicare solvency divides Republicans at the presidential debate

Covid's long

Biotech incubator Curie.Bio graduates its first startup

focus

entertainment

Sign up for D.C. Diagnosis

explore

Sports medicine is finally prioritizing gender equality

Study: New antibiotic targets gonorrhea as well as last existing drug

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Duchenne breakthrough therapy leaves behind pioneering families

Maui funeral service workers on devastation of fires: 'I'm in shock'

Psychedelics group wrestles with new pharma identity

Pharma budget tightening trickles down to Doximity

Sports medicine is finally prioritizing gender equality

Timeline: Special counsel's investigation into Trump's handling of classified documents

focus

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

STAT Executive Editor Rick Berke on STAT's 8th birthday

Sanofi CEO defends move to abandon profit guidance, boost research

Sanofi CEO defends move to abandon profit guidance, boost research

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Listen: Your guide to Wegovy's blockbuster heart study

focus

Wikipedia

focus

hotspot